This session is not sponsored or programmed by the American Neurological Association. The speakers are presenting on behalf of, and are paid consultants for Med Learning Group.
Monday, October 19, 2026
3:45 PM PT – 4:00 PM PT: Registration & Refreshments
4:00 PM PT – 5:00 PM PT: CME Symposium & Refreshments
Sheraton San Diego Resort
1380 Harbor Island Drive
San Diego, CA 92101
Meeting Room: Silver Pearl Ballroom 1
PRESENTING FACULTY
 |
Namita A. Goyal, MD, FAAN Professor, Department of Neurology Chief, Neuromuscular Division Director, Neuromuscular and ALS Center University of California, Irvine Irvine, California |
 |
Leo H. Wang, MD, PhD, FAAN Professor, Department of Neurology University of Washington Seattle, Washington |
PROGRAM OVERVIEW
This interactive live and online symposium is designed to enhance the knowledge and clinical competence of clinicians involved in the management of generalized myasthenia gravis (gMG). Expert faculty will review the clinical features, diagnostic criteria, and disease burden associated with gMG, including factors that contribute to diagnostic delays. Participants will examine the rationale and latest clinical evidence for novel B-cell–targeted therapies and explore practical approaches to individualizing treatment selection, shared decision-making, patient counseling, and longitudinal follow-up to support personalized long-term management.
TARGET AUDIENCE
This activity is designed to meet the educational needs of neurologists, neuromuscular specialists, and specialty NPs/PAs.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Apply assessment of clinical features, diagnostic criteria, and disease burden to inform gMG management
- Integrate clinical efficacy and safety data for novel B-cell targeted therapies to inform treatment plans for gMG
- Create shared decision-making approaches to personalize the long-term management of patients with gMG
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this live activity for a maximum of up to 1.0 ANCC contact hour.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to the live event at [email protected]
